Publications by authors named "Saygin Gonderten"
Article Synopsis
- OVERCOME (EU) is a study focusing on migraine and severe headaches in Spain and Germany, part of a larger international research project.
- The survey gathered data from adults who experienced migraines in the past year, analyzing both overall and subcohort cases with more intense symptoms.
- Results indicated that the majority of participants experienced moderate to severe pain, many reported significant disability and reduced quality of life, and while most used acute medications, only a minority used triptans specifically.
Background: Insights into the burden, needs and treatment of migraine from internet-based surveys in diverse real-world migraine populations are needed, especially at a time when novel preventive migraine medications are becoming part of the therapeutic armamentarium. The objectives of this analysis are to describe traditional preventive (orals and onabotulinum toxin A) treatment patterns in the OVERCOME (EU) study migraine cohort, as well as treatment patterns and patient satisfaction with current treatment in a subgroup of respondents eligible for migraine preventive medication.
Methods: The cross-sectional non-interventional OVERCOME (EU) study was conducted (October 2020-February 2021) via an online survey among adults (aged ≥ 18 years) resident in Germany or Spain.
Introduction: The aim of this study was to re-evaluate jitter values of healthy subjects in whom pairs of single-fiber-like potentials were recorded from voluntary activated periocular muscles using a disposable 37-mm concentric needle electrode (CNE) with 2-kHz low-cut filtering.
Methods: We reviewed the recordings of 129 subjects (85 women; 44 men; mean age, 43.8±15.